StonvexLoading…
StonvexStonvexStonvexCore line items from HLI's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2026 2026-03-31 | Q4 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $2.62B | $1.98B | $1.26B | $605.35M |
Operating Income | $527.02M | $401.87M | $241.14M | $89.80M |
Net Income | $425.70M | $325.86M | $209.31M | $97.53M |
EPS (Diluted) | $6.22 | $4.74 | $3.04 | $1.42 |
Total Assets | $4.31B | $3.94B | $3.79B | $3.52B |
Total Liabilities | $1.86B | $1.64B | $1.55B | $1.34B |
Cash & Equivalents | $1.19B | $1.06B | $923.58M | $793.82M |
Free Cash Flow OCF − CapEx | $681.82M | $395.04M | $177.99M | $-144.81M |
Shares Outstanding | 68.43M | 68.69M | 68.76M | 68.89M |